Acrivon Therapeutics, Inc.·4

Oct 3, 6:49 PM ET

Miller Mary 4

4 · Acrivon Therapeutics, Inc. · Filed Oct 3, 2024

Insider Transaction Report

Form 4
Period: 2024-10-01
Miller Mary
Chief Legal Officer
Transactions
  • Tax Payment

    Common Stock

    2024-10-01$6.98/sh284$1,98238,683 total
Footnotes (1)
  • [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Documents

1 file
  • 4
    form4.xmlPrimary